Fischer et al. showed that patients with multiple myeloma (MM) with a smaller proportion (among T cells) of CD25+CD127low Regulatory T cells (Tregs) at lymphodepletion were associated with improved response to CAR-T treatment and also had a higher maximum C-reactive protein (CRP; an indicator of CRS) (14). Here, CRP is linked to plasma cell myeloma.